West Pharmaceutical Services
Yahoo Finance • 4 days ago
West to Host Third-Quarter 2026 Conference Call
EXTON, Pa., Oct. 8, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter financial results befor... Full story
Yahoo Finance • 20 days ago
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
iRhythm Holdings IRTC is well-positioned for solid growth over the next few quarters, courtesy of its strong second-quarter 2026 results and structural market expansion. The company's investments in AI, large-scale ECG data and clinical va... Full story
Yahoo Finance • 20 days ago
1 S&P 500 Stock with Exciting Potential and 2 We Ignore
1 S&P 500 Stock with Exciting Potential and 2 We Ignore While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, o... Full story
Yahoo Finance • 24 days ago
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC
Avantor, Inc. AVTR recently expanded the availability of RIM single-use bioprocessing portfolio across the Asia Pacific (APAC) region, strengthening its presence in a key biopharma manufacturing market. The move aims to provide regional cu... Full story
Yahoo Finance • 24 days ago
Reasons to Add West Pharmaceutical Stock to Your Portfolio Now
West Pharmaceutical Services, Inc. WST is well positioned for growth, backed by strong demand for HVPs, expanding biologics exposure and regulatory-driven Annex 1 conversions. However, tariff impacts and weak West Vantage results, which we... Full story
Yahoo Finance • 25 days ago
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now
Solventum Corporation SOLV is well-poised for growth in the coming quarters, driven by strong demand across its business segments, supported by continued investment in innovation, R&D and digital capabilities. The optimism, led by a solid... Full story
Yahoo Finance • 26 days ago
ISRG Wins EU Nod to Expand da Vinci SP in Gynecologic Procedures
Intuitive Surgical ISRG recently announced that its da Vinci SP surgical system received CE mark approval in Europe for transvaginal gynecologic procedures, expanding the platform's approved applications in the region and marking a new mil... Full story
Yahoo Finance • 27 days ago
Here's Why You Should Add BrightSpring Stock to Your Portfolio Now
BrightSpring Health Services, Inc. BTSG is well-poised for growth in the coming quarters, backed by strong momentum in Provider Services, expanding specialty and infusion operations, expanding specialty pharmacy opportunities beyond oncolo... Full story
Yahoo Finance • 27 days ago
BDX Deploys Vmax 160 to Advance Intelligent Pharmacy Automation
Becton, Dickinson and Company BDX, popularly known as BD, recently advanced its pharmacy automation portfolio in the United States with the deployment of BD Vmax 160, its next-generation pharmacy automation robot at Fairview Health Service... Full story
Yahoo Finance • 29 days ago
Notable healthcare headlines for the week: UnitedHealth, Amgen, and CooperCompanies in focus
Wall Street rallied on Friday after the latest consumer inflation report came in broadly in line with expectations, helping ease concerns over price pressures and supporting a rebound across risk assets. On Friday, the Dow Jones Industria... Full story
Yahoo Finance • last month
IceCure Secures China NMPA Approval for ProSense Cryoablation System
IceCure Medical ICCM recently secured regulatory approval from China's National Medical Products Administration ("NMPA") for its ProSense cryoablation system and associated cryoprobes. The clearance marks a key milestone in the company's i... Full story
Yahoo Finance • last month
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
DaVita Inc. DVA has been gaining from strong execution across its Integrated Kidney Care (IKC) platform, improving treatment volumes and investments in technology and clinical innovation. The optimism is led by solid first-quarter 2026 res... Full story
Yahoo Finance • last month
GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance
GE HealthCare Technologies Inc. GEHC recently announced that it is taking its next-generation StarGuide GX digital 4D cadmium zinc telluride (CZT) SPECT/CT system closer to the U.S. market with the submission to the FDA for 510(k) clearanc... Full story
Yahoo Finance • last month
Here's Why You Should Retain AMN Stock in Your Portfolio for Now
AMN Healthcare Services, Inc. AMN is well-poised for growth in the coming quarters, courtesy of its broad array of services. The optimism is led by strong momentum in its Managed Services Program (MSP), favorable healthcare staffing demand... Full story
Yahoo Finance • last month
Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial
Nyxoah NYXH recently initiated its U.S. post-approval BREATHE study with the first patient implanted using the Genio system, marking an important step in expanding clinical evidence for its obstructive sleep apnea therapy following FDA app... Full story
Yahoo Finance • last month
Philips Expands Women's Health Ultrasound Portfolio With New Transducer
Koninklijke Philips PHG has expanded its women's health ultrasound portfolio with the launch of the eV14-2v transvaginal transducer, designed for gynecology and early obstetrics imaging. The FDA 510(k)-cleared and CE-marked solution will b... Full story
Yahoo Finance • last month
Novocure Reports Patient Data Exposure in Cybersecurity Incident
Novocure Limited NVCR recently disclosed that it identified unauthorized access to certain information systems through a subsidiary in mid-August 2026. Following detection, the company activated its cybersecurity response plan, implemented... Full story
Yahoo Finance • last month
Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity?
Generation Investment Management, an investment management firm, released its "Global Equity Strategy" second quarter 2026 investor letter. The letter can be downloaded here. The letter discusses the challenges of AI-driven market concentr... Full story
Yahoo Finance • last month
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HealthEquity, Inc. HQY has been benefiting from its business model and strategy. The optimism, led by a solid second-quarter fiscal 2027 performance and strength in Health Savings Accounts (HSAs), is expected to contribute further. However... Full story
Yahoo Finance • last month
Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now
NeuroPace, Inc. NPCE is well-positioned for solid growth, driven by strong RNS adoption, favorable RNS reimbursement, expanding referral networks and AI-driven innovations that enhance efficiency and utilization. The potential IGE indicati... Full story